Breaking News Instant updates and real-time market news.

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:25
07/22/19
07/22
16:25
07/22/19
16:25

Viveve trading halted, news pending

VIVE Viveve
$0.41

-0.0155 (-3.68%)

07/31/18
MZHO
07/31/18
NO CHANGE
Target $4
MZHO
Buy
Seven Viveve competitors get FDA warning letters, says Mizuho
The FDA issued a warning letter to seven competitors of Viveve Medical related to the inappropriate marketing of energy-based devices for the treatment of vaginal rejuvenation, Mizuho analyst Difei Yang tells investors in a research note. The analyst anticipates the competitors will likely stop marketing their devices "off label" in the near term. Since Viveve has not received a letter, Yang sees the development as a positive for the company. The letters to competitors will likely provide an opportunity to compete on equal footing with more established players, especially considering Viveve has received two investigational device exemptions from the FDA to conduct clinical trials in both sexual function and stress urinary incontinence, Yang tells investors in a research note. She reiterates a Buy rating on Viveve shares with a $4 price target.
12/07/18
LTCO
12/07/18
NO CHANGE
Target $8.5
LTCO
Buy
Viveve data supports ongoing clinical activity in SUI, says Ladenburg
After Viveve announced 12-month data from its stress urinary incontinence, or SUI, study, Ladenburg analyst Jeffrey Cohen said he believe this data supports ongoing clinical activity and provides additional support for the LIBERATE International and LIBERATE U.S. studies. He reiterates his Buy rating and $8.50 price target on Viveve shares.
01/02/19
STFL
01/02/19
NO CHANGE
Target $19
STFL
Buy
Sientra added to Select List, IntriCon removed at Stifel
Stifel analyst Jonathan Block added Sientra (SIEN) to the firm's Select List, replacing IntriCon (IIN). His survey of 70 dermatologists, 48 plastic surgeons and 25 other doctors "paints a bullish picture" for adoption of Sientra's miraDry over the next 12-24 months, Block tells investors. The overall shift to non-invasive procedures is expected to continue and it appears that miraDry will play a central role, Block added. He keeps a Buy rating on Sientra shares, though he lowered his price target on the stock to $19 from $24. He also cut his price target on Cutera (CUTR) to $17 from $29 and lowered his price target on Viveve (VIVE) to $3 from $5 following his survey work. Block keeps a Hold rating on Cutera and Buy rating on Viveve.
07/11/19
STFL
07/11/19
NO CHANGE
Target $3
STFL
Buy
Viveve checks suggest SUI trial endpoint will be hit, says Stifel
Stifel analyst Jonathan Block said in a note issued last night that his checks with 21 current North American Viveve practices lead him to believe there is a "high likelihood" that the primary endpoint for the company's LIBERATE-International stress urinary incontinence, SUI, trial will be hit. If he is correct, he thinks it would be a catalyst for the shares, though he noted that "several challenges would still remain," including balance sheet concerns. Block keeps a Buy rating and $3 price target on Viveve shares, which are up 6c, or 15%, to 45c in morning trading.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/16/19
09/16
16:20
09/16/19
16:20
Options
Closing CBOE SPX and VIX Index summary for September 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$118.42

0.8 (0.68%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 13

    Nov

ABEO

Abeona Therapeutics

$3.00

0.035 (1.18%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Hot Stocks
Great Point Partners reports 5.7% passive stake in Abeona Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECPG

Encore Capital

$35.05

0.66 (1.92%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Hot Stocks
Encore Capital appoints Tracy Ting Chief Human Resources Officer »

Encore Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$99.32

-0.19 (-0.19%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Initiation
Nasdaq initiated  »

Nasdaq initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ZGNX

Zogenix

$41.87

0.28 (0.67%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
Great Point Partners reports 5.3% passive stake in Zogenix »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTI

OPTi Inc.

$0.00

(0.00%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
OPTi Inc. in 'strategic' pact with DR Microgrids »

OPTEC International forms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$29.45

-0.46 (-1.54%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Conference/Events
Arrowhead management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
Aclaris says Phase 3 trial meets all primary, secondary endpoints »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$30.09

-0.01 (-0.03%)

16:17
09/16/19
09/16
16:17
09/16/19
16:17
Hot Stocks
SeaWorld CEO Gustavo Antorcha resigns, Marc Swanson named interim CEO »

SeaWorld announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/16/19
09/16
16:17
09/16/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
09/16/19
09/16
16:16
09/16/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$77.36

-0.74 (-0.95%)

16:16
09/16/19
09/16
16:16
09/16/19
16:16
Conference/Events
Addus HomeCare management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

16:15
09/16/19
09/16
16:15
09/16/19
16:15
Hot Stocks
Tonix Pharmaceuticals announces licensing pact with Columbia University »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 25

    Sep

XOM

Exxon Mobil

$73.76

1.13 (1.56%)

, CVX

Chevron

$124.13

2.67 (2.20%)

16:14
09/16/19
09/16
16:14
09/16/19
16:14
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks were lower, and…

XOM

Exxon Mobil

$73.76

1.13 (1.56%)

CVX

Chevron

$124.13

2.67 (2.20%)

WLL

Whiting Petroleum

$11.23

3.7 (49.14%)

DNR

Denbury Resources

$1.56

0.35 (28.93%)

XOG

Extraction Oil & Gas

$4.17

0.95 (29.50%)

CDEV

Centennial Resource Development

$5.80

1.39 (31.52%)

GM

General Motors

$37.19

-1.64 (-4.22%)

NXST

Nexstar

$107.16

5.03 (4.93%)

TRCO

Tribune Media

$46.65

0.03 (0.06%)

BX

Blackstone

$53.51

-0.04 (-0.07%)

MGM

MGM Resorts

$29.69

0.65 (2.24%)

CNHI

CNH Industrial

$11.17

-0.03 (-0.27%)

ALDR

Alder Biopharmaceuticals

$18.68

8.63 (85.87%)

SEMG

SemGroup

$16.50

6.22 (60.51%)

ET

Energy Transfer LP

$13.41

-0.6 (-4.28%)

NEWR

New Relic

$58.44

0.1 (0.17%)

MNK

Mallinckrodt

$3.01

-0.29 (-8.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 23

    Sep

  • 26

    Sep

  • 26

    Sep

  • 08

    Oct

  • 09

    Oct

  • 21

    Oct

  • 07

    Nov

  • 13

    Nov

  • 21

    Feb

APA

Apache

$28.46

4.13 (16.97%)

16:14
09/16/19
09/16
16:14
09/16/19
16:14
Initiation
Apache initiated  »

Apache initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 13

    Nov

ALDR

Alder Biopharmaceuticals

$18.59

8.54 (84.98%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Downgrade
Alder Biopharmaceuticals rating change  »

Alder Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 21

    Feb

CME

CME Group

$207.10

1.35 (0.66%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Initiation
CME Group initiated  »

CME Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$91.87

1.04 (1.15%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Initiation
IntercontinentalExchange initiated  »

IntercontinentalExchange…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

NDAQ

Nasdaq

$99.21

-0.3 (-0.30%)

16:12
09/16/19
09/16
16:12
09/16/19
16:12
Initiation
Nasdaq initiated  »

Nasdaq initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CBOE

Cboe Global Markets

$111.07

0.21 (0.19%)

16:11
09/16/19
09/16
16:11
09/16/19
16:11
Initiation
Cboe Global Markets initiated  »

Cboe Global Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBCP

Concrete Pumping

$4.33

0.195 (4.72%)

16:10
09/16/19
09/16
16:10
09/16/19
16:10
Earnings
Concrete Pumping sees FY19 revenue $284M, consensus 292.54M »

The company now expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

BBCP

Concrete Pumping

$4.33

0.195 (4.72%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Earnings
Concrete Pumping reports Q3 EPS 5c, consensus 7c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

MRVL

Marvell

$25.42

-0.43 (-1.66%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Marvell's Gaynor sells 35,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAST

Eastside Distilling

$4.99

-0.01 (-0.20%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Eastside Distilling acquires Azunia Tequila in all-stock transaction »

Eastside Distilling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.